Pharma Regulators
Pharma Regulators sits in the SectoralRegs phase of GovOS — AJG's synthesis of the global rule-making infrastructure. Pharmaceuticals require national approval before import. India: CDSCO (Central Drugs Standard Control Organization). US: FDA CDER. EU: EMA + national agencies. Japan: PMDA. ICH harmonisation eases data sharing. WHO PQ helps developing-country procurement. Reach: USD 1.5T+ global pharma market. Cadence: NDA: 1-2 years; generic: 6-12 months. Multilateral coverage: 197 countries × 273 FTAs × 28 blocs.
Primary actors
8-Slice Structural Map
Every pharma regulators interaction touches each of these structural slices. Click through to deep-dive each.
Other SectoralRegs-phase entries
All 6 GovOS phases
Need to map pharma regulators to a specific country, sector, or transaction? AJG's governance research synthesises the practical implications of every framework.
+91 9888 1471 47 · enquiry@allfrontierglobal.com · WhatsApp +91 9888 1471 47
Frequently asked about Pharma Regulators
What is the reach of Pharma Regulators?
USD 1.5T+ global pharma market
How often is Pharma Regulators updated?
NDA: 1-2 years; generic: 6-12 months
Who are the primary actors in Pharma Regulators?
cdsco, usfda-cder, ema, pmda, who-pq.
Does Pharma Regulators apply across all 197 countries?
GovOS is multilateral by construction. Some categories are universal (WTO, WCO); others are jurisdiction-specific (DGFT for India, USTR for US). Country-specific applications are surfaced via /os/govos/country/{country}/.
How does this relate to AJG's broader trade-intelligence platform?
GovOS is the rule-making layer atop AJG's data substrate. It complements TradeOS (operations) and DealOS (deal structures). Cross-OS triads — DealOS × TradeOS × GovOS — surface the strategic + operational + regulatory views together.